Whitney Ijem
Stock Analyst at Canaccord Genuity
Total Price Targets
17
Stocks Covered
10
Sectors
Healthcare
Most Recent
Apr 10, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Whitney Ijem
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| PHAR | Pharming Group N.V. | $37.00 | $16.65 | +122.2% | 1 | Apr 10, 2026 |
| BMRN | BioMarin Pharmaceutical Inc. | $104.00 | $54.20 | +91.9% | 2 | Feb 26, 2026 |
| GUTS | Fractyl Health, Inc. Common Stock | $8.00 | $0.69 | +1066.5% | 1 | Dec 19, 2025 |
| PVLA | Palvella Therapeutics, Inc. | $204.00 | $125.87 | +62.1% | 2 | Dec 16, 2025 |
| RYTM | Rhythm Pharmaceuticals, Inc. | $141.00 | $82.41 | +71.1% | 1 | Dec 12, 2025 |
| RCKT | Rocket Pharmaceuticals, Inc. | $39.00 | $3.56 | +994.0% | 2 | Nov 11, 2024 |
| ARCT | Arcturus Therapeutics Holdings Inc. | $10.58 | $8.64 | +22.4% | 3 | Nov 11, 2024 |
| ALNY | Alnylam Pharmaceuticals, Inc. | $336.00 | $297.62 | +12.9% | 3 | Oct 24, 2024 |
| VRTX | Vertex Pharmaceuticals Incorporated | $361.00 | $425.06 | -15.1% | 1 | Oct 22, 2024 |
| RARE | Ultragenyx Pharmaceutical Inc. | $111.00 | $24.79 | +347.9% | 1 | May 31, 2024 |
Recent Activity
- Apr 10, 2026— Set$37.00price target onPHAR(Pharming Group N.V.)
- Feb 26, 2026— Set$104.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Dec 19, 2025— Set$8.00price target onGUTS(Fractyl Health, Inc. Common Stock)
- Dec 16, 2025— Set$204.00price target onPVLA(Palvella Therapeutics, Inc.)
- Dec 12, 2025— Set$141.00price target onRYTM(Rhythm Pharmaceuticals, Inc.)
- May 16, 2025— Set$52.00price target onPVLA(Palvella Therapeutics, Inc.)
- Nov 11, 2024— Set$39.00price target onRCKT(Rocket Pharmaceuticals, Inc.)
- Nov 11, 2024— Set$10.58price target onARCT(Arcturus Therapeutics Holdings Inc.)
- Oct 24, 2024— Set$336.00price target onALNY(Alnylam Pharmaceuticals, Inc.)
- Oct 22, 2024— Set$361.00price target onVRTX(Vertex Pharmaceuticals Incorporated)
- Oct 1, 2024— Set$366.00price target onALNY(Alnylam Pharmaceuticals, Inc.)
- Sep 18, 2024— Set$38.00price target onRCKT(Rocket Pharmaceuticals, Inc.)
- Aug 6, 2024— Set$93.00price target onBMRN(BioMarin Pharmaceutical Inc.)
- Aug 6, 2024— Set$10.30price target onARCT(Arcturus Therapeutics Holdings Inc.)
- Jul 8, 2024— Set$357.00price target onALNY(Alnylam Pharmaceuticals, Inc.)
- May 31, 2024— Set$111.00price target onRARE(Ultragenyx Pharmaceutical Inc.)
- May 10, 2024— Set$12.30price target onARCT(Arcturus Therapeutics Holdings Inc.)
Frequently Asked Questions
Who is Whitney Ijem?
Whitney Ijem is a stock analyst at Canaccord Genuity covering 10 stocks primarily in Healthcare. They have issued 17 price targets since May 10, 2024.
What stocks does Whitney Ijem cover?
Whitney Ijem currently covers 10 stocks, including ARCT, ALNY, BMRN, PVLA, RCKT.
What is Whitney Ijem's latest price target?
Whitney Ijem's most recent price target was $37.00 on PHAR (Pharming Group N.V.), set on Apr 10, 2026.
What is Whitney Ijem's highest price target?
Whitney Ijem's highest issued price target is $366.00 on ALNY, set on Oct 1, 2024.
More Analysts at Canaccord Genuity
Coverage based on publicly published price targets. Not investment advice.